Detalhe da pesquisa
1.
A model of primary culture of colorectal cancer and liver metastasis to predict chemosensitivity.
J Surg Res
; 166(2): 247-54, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19691974
2.
Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit.
J Biol Chem
; 284(42): 29136-45, 2009 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19648112
3.
Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents.
Int J Cancer
; 127(5): 1028-37, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20017140
4.
IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells.
Int J Cancer
; 124(6): 1449-56, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19065668
5.
STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
Clin Cancer Res
; 14(2): 597-606, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18223236
6.
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Drug Resist Updat
; 11(4-5): 123-51, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18718806
7.
IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents.
Mol Cancer Ther
; 7(8): 2426-34, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723488
8.
What's new on CDC25 phosphatase inhibitors.
Pharmacol Ther
; 115(1): 1-12, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17531323
9.
The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine.
Eur J Pharmacol
; 594(1-3): 70-6, 2008 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18664366
10.
Synthesis and bioevaluation of 22-hydroxyacuminatine analogs.
Bioorg Med Chem Lett
; 18(6): 2143-6, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18276141
11.
Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia.
Cancer Res
; 66(14): 7128-35, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16854822
12.
Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.
Cancer Res
; 66(18): 9227-34, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16982767
13.
Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly.
Mol Cancer Ther
; 6(1): 318-25, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17237290
14.
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.
Mol Cancer Ther
; 5(6): 1446-51, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16818502
15.
BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo.
Cancer Res
; 64(14): 4942-9, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15256467
16.
A novel synthetic inhibitor of CDC25 phosphatases: BN82002.
Cancer Res
; 64(9): 3320-5, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15126376
17.
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases.
Mol Cancer Ther
; 4(9): 1378-87, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16170030
18.
Apoptosis and TRAF-1 cleavage in Epstein-Barr virus-positive nasopharyngeal carcinoma cells treated with doxorubicin combined with a farnesyl-transferase inhibitor.
Biochem Pharmacol
; 65(3): 423-33, 2003 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12527335
19.
Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.
Oncotarget
; 5(16): 6687-700, 2014 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25149532
20.
Correction: A Functional Screen Identifies Specific MicroRNAs Capable of Inhibiting Human Melanoma Cell Viability.
PLoS One
; 8(1)2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-29364961